Key result
Alcohol use disorder linked to ~235% more 90-day medical complications after reverse shoulder arthroplasty.
Why the study?
The impact of alcohol use disorder on lengths of stay, complications, and costs following primary reverse shoulder arthroplasty was not well defined.
Does alcohol use disorder increase length of stay, complications, and costs in patients undergoing primary reverse shoulder arthroplasty?
Cohort (n=19,168)
Does alcohol use disorder increase length of stay, complications, and costs in patients undergoing primary reverse shoulder arthroplasty?
Absolute Event Rate: 49.59% vs 14.81%
p-value: p=<0.0001
Alcohol use disorder is associated with increased length of stay, higher complication rates, and greater costs following primary reverse shoulder arthroplasty.
May warrant preoperative screening in reverse shoulder arthroplasty; hypothesis-generating for targeted interventions.
The purpose of this study was to determine whether alcohol use disorder (AUD) patients undergoing reverse shoulder arthroplasty (RSA) have increased: 1) lengths of stay (LOS); 2) complications; and 3) costs. The study identified 19,168 patients in the study (n = 3198) and control (n = 15,970) cohort. In-hospital LOS, 90-day complications, and costs were assessed. AUD patients had significantly longer LOS (3- vs. 2-days, p < 0.0001), higher9 0-day medical complications (49.59 vs. 14.81%; p < 0.0001), and 90-day costs of care ($18,763.25 vs. $16,035.49, p < 0.0001). The study is useful as it can allow healthcare professionals to adequately counsel these patients.
No takes yet. Share an insight, caveat, or question.
Nassis et al. (2021) conducted a cohort in Primary reverse shoulder arthroplasty (n=19,168). Alcohol use disorder vs. No alcohol use disorder (matched controls) was evaluated on 90-day medical complications (p=<0.0001). Alcohol use disorder in patients undergoing reverse shoulder arthroplasty was associated with higher 90-day medical complications (49.59% vs. 14.81%, p<0.0001), longer lengths of stay, and higher costs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: